Companies like PepsiCo, Lupin and Axis Bank are among companies that have pay equity as the mainstay of their employee agenda and vouch for...

The domestic pharma sector may have been drawing top dollar deals and driving M&As based on opportunities of growth, but stock markets seem...

“In the case of banks, there have been strong results to support the rally, improving fundamentals. But in IT, the numbers were weakish exc...

The development assumes significance amid weakness in the broader economy as fund managers say companies need strong boards to get through ...

Tune in: Financial market updates you need to have before the day ends

The domestic equity market ended on a negative note on Friday on account of profit booking.

In a two years, 40% of the top stocks he holds have delivered negative returns. Only Escorts and Aptech more than doubled investor wealth i...

The WHO said its findings bring into question the validity of studies (performed for 12 products) that are under assessment, but not prequa...

Equitas may be much better stock to go into rather than any of the current financial stocks.

I will still go for stocks like Aurobindo, Lupin, Cadila Healthcare and may be Divi's Labs, says Tandon. The expert says he is not so posit...

"When we look at the analysis of pharmaceutical industry and look projected forward, you cannot even imagine what we are looking at."

Despite tough conditions, these cos have reported a better performance by exploring opportunities through a combination of internal & exter...

The companies in the 50-share Nifty index may report a 17.6% year-on-year growth in operating profit for the third quarter - the best in si...

Robust growth in profits despite modest rise in revenues characterised the performance of the Indian pharma sector for the latest quarter e...

Software exporters Wipro, Tata Consultancy Services and ADA Group firm Reliance Natural Resources are among the companies which have caught...

Pharmaceutical firms and makers of consumer goods such as soaps and shampoos are considered as reliable defensive bets in times of economic...

The pharma industry has turned the old maxim, ‘wisdom comes with age’, on its head.